Fit Living In Progress
Fit Living In Progress · 65 Duke Street · Prince Frederick, MD 20678
5.0· 71 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Care described on the practice's website
- Medically supervised weight loss
About this practice
Fit Living In Progress (FLiP) is an integrative wellness practice in Prince Frederick, Maryland, offering medical aesthetics, weight loss and IV services, with telehealth listed. Its website says care is led by Joseph Christensen, APRN, FNP-BC, and Brent Lankford, BSN, RN, CEN, CPEN, TCRN, and focuses on root causes rather than only symptoms, treating weight as a window into overall health. Reviews on Google started in 2025 and now number 71 at 5.0 stars, 61 of them in the past year, with the providers' knowledge, the staff, results and a caring manner all frequently mentioned.
Services & access
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Yes |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-10. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★5.0 across 71 Google reviews. Of the 68 reviews we analyzed, 68 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).
What patients like
- Friendly, helpful staff26 reviews
- Knowledgeable, professional providers26 reviews
- Feeling listened to18 reviews
- Weight-loss results16 reviews
Common complaints
No negative reviews among those we analyzed.
Most recent Google reviews
Kristen S.★★★★★2026-09-10I had a great experience with Fit Living in Progress! I was able to book a same-day appointment and received confirmation very quickly, which I really appreciated. The entire visit went smoothly, and N.P. Christensen was wonderful. He was very personable, professional, and made me feel comfortable throughout the appointment. I never felt rushed, and the overall experience was easy and welcoming. I would definitely recommend Fit Living in Progress to anyone looking for professional and personable care!
Jennifer J.★★★★★2026-09-06Thanks to Joe, Brent and the team at Fit Living. Caring and kind, providing exceptional care.
Stacey L.★★★★★2026-09-03I have had great experiences with FLIP. The entire staff is friendly and professional. Joe is knowledgeable, attentive, and takes the time to answer any questions I may have.
cecilia p.★★★★★2026-08-26Meeting Jenn for cool sculpture consultation was incredibly comfortable and very simple-no pressure at all- made me feel in great hands .. I will definitely move forward with all the confidence in Jenn and the entire staff.. Cecilia Poole
Susan S.★★★★★2026-08-15Flip is top notch, we get IV’s weekly at flip and they have been amazing for us! Highly recommend these folks!
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs